Catabasis Pharmaceuticals, Inc. (Nasdaq: CATB) to Ring The Nasdaq Stock Market Closing Bell
November 16 2016 - 1:00PM
What:Catabasis Pharmaceuticals,
Inc. (Nasdaq:CATB), a clinical-stage biopharmaceutical company,
will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Jill C. Milne, Co-Founder and
CEO, will ring the Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Thursday, November 17, 2016 – 3:45 p.m. to
4:00 p.m. ET
Catabasis Contact:Andrea Matthews(617)
349-1971amatthews@catabasis.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About CatabasisAt Catabasis
Pharmaceuticals, our mission is to bring hope and life-changing
therapies to patients and their families. Our SMART (Safely
Metabolized And Rationally Targeted) linker drug discovery platform
enables us to engineer molecules that simultaneously modulate
multiple targets in a disease. We are applying our SMART linker
platform to build an internal pipeline of product candidates for
rare diseases and plan to pursue partnerships to develop additional
product candidates. For more information on the Company's drug
discovery platform and pipeline of drug candidates, please visit
www.catabasis.com.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 70 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
more than 3,700 listed companies with a market value of $10
trillion and approximately 18,000 corporate clients. To learn more,
visit: nasdaq.com/ambition or business.nasdaq.com
-NDAQA-
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Apr 2023 to Apr 2024